DNA Dividend: Ginkgo Bioworks Holdings Inc Yield Insights
Home
Stock
DNA
Ginkgo Bioworks Holdings Inc (DNA) Price
DNA Stock Price Chart
DNA Financial
Ginkgo Bioworks Holdings Inc
$8.77
-2.01%
$-0.17
$8.7
-0.76%
$-0.06
Overview
Forecast
Earning
Dividends
Financials
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Market Sentiment
Technical Analysis
Crypto Comparison
Home Page
Trading Strategies
Megabrain Investors Picks
Trading Mindshare
Technical Signals
Pivot Alert
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
Stocks Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2025 Edgen Powered by
Ask AI About DNA
Income
Balance sheet
Cash flow
Annual
Quarterly
DNA Income
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue
230
227
251
477
313
76
Revenue Growth (YoY)
25%
-10%
-47%
52%
312%
41%
Cost of Revenue
48
44
54
204
129
15
Gross Profit
182
182
197
273
184
61
Selling, General & Admin
208
241
192
1,383
863
38
Research & Development
277
424
580
1,052
1,149
159
Operating Expenses
486
665
773
2,436
2,012
198
Other Non Operating Income (Expenses)
13
28
14
132
80
16
Pretax Income
-316
-547
-892
-2,121
-1,838
-124
Income Tax Expense
0
0
0
-15
-1
1
Net Income
-315
-547
-892
-2,104
-1,830
-126
Net Income Growth
-65%
-39%
-57.99%
15%
1,352%
6%
Shares Outstanding (Diluted)
54.85
51.89
48.61
1,679.1
1,359.8
1,874.8
Shares Change (YoY)
7%
7%
-97%
23%
-27%
0%
EPS (Diluted)
-5.74
-10.54
-18.36
-1.25
-1.35
-0.07
EPS Growth
-67%
-43%
1,369%
-7%
1,829%
17%
Free Cash Flow
-274
-382
-336
-304
-310
-193
Free Cash Flow Per Share
-4.99
-7.36
-6.91
-0.18
-0.22
-0.1
Gross Margin
79.13%
80.17%
78.48%
57.23%
58.78%
80.26%
Operating Margin
-132.17%
-212.77%
-229.48%
-453.24%
-584.02%
-180.26%
Profit Margin
-136.95%
-240.96%
-355.37%
-441.09%
-584.66%
-165.78%
Free Cash Flow Margin
-119.13%
-168.28%
-133.86%
-63.73%
-99.04%
-253.94%
EBITDA
-241
-420
-506
-2,120
-1,799
-124
EBITDA Margin
-104.78%
-185.02%
-201.59%
-444.44%
-574.76%
-163.15%
D&A For EBITDA
63
63
70
42
29
13
EBIT
-304
-483
-576
-2,162
-1,828
-137
EBIT Margin
-132.17%
-212.77%
-229.48%
-453.24%
-584.02%
-180.26%
Effective Tax Rate
0%
0%
0%
0.7%
0.05%
-0.8%
Follow-Up Questions
Ginkgo Bioworks Holdings Inc 的关键财务报表是什么?
DNA 的关键财务比率是什么?
Ginkgo Bioworks Holdings Inc 的收入按细分市场或地理位置如何划分?
Ginkgo Bioworks Holdings Inc 是否盈利?
Ginkgo Bioworks Holdings Inc 有负债吗?
Ginkgo Bioworks Holdings Inc 的流通股有多少?